Acuta Capital Partners, LLC Ampio Pharmaceuticals, Inc. Transaction History
Acuta Capital Partners, LLC
- $98.8 Million
- Q3 2024
A detailed history of Acuta Capital Partners, LLC transactions in Ampio Pharmaceuticals, Inc. stock. As of the latest transaction made, Acuta Capital Partners, LLC holds 325,000 shares of AMPE stock, worth $0. This represents 0.18% of its overall portfolio holdings.
Number of Shares
325,000Holding current value
$0% of portfolio
0.18%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding AMPE
# of Institutions
1Shares Held
96.6KCall Options Held
0Put Options Held
0About Ampio Pharmaceuticals, Inc.
- Ticker AMPE
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 226,287,008
- Description
- Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...